What Researchers Did
Researchers tested whether HBOT could prevent bone loss in a rat model of periodontitis, measuring its effect on RANKL and OPG -- proteins that regulate bone breakdown and formation.
What They Found
HBOT at 2.0 ATA significantly reduced alveolar bone loss in the periodontitis model by decreasing RANKL expression and increasing OPG levels. The treated rats showed less inflammatory cell infiltration in gum tissue.
What This Means for Canadian Patients
Periodontitis-related bone loss is a significant dental health problem. These preclinical findings support investigation of HBOT as an adjunct to periodontal treatment, particularly for patients with refractory disease.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Rat periodontal models do not fully replicate the complexity of human chronic periodontitis.